Oxford BioMedica: Notice of Interim Results

22 July 2013

Results date: 29 August 2013

Oxford, UK – 23 July 2013: Oxford BioMedica plc (“Oxford BioMedica” or “the Company”) (LSE: OXB), the leading gene-based biopharmaceutical company, will be announcing its interim results for the six months ended 30 June 2013 on Thursday, 29 August 2013.

An analyst briefing will be held at 09:30am GMT on Thursday, 29 August 2013 at the offices of M:Communications, 11th Floor, CityPoint, 1 Ropemaker Street, London, EC2Y 9AW.  An audio replay will be made available shortly after the presentation on the Company’s website: www.oxfordbiomedica.co.uk.